Persistence rates highlight unmet need for effective lupus therapies

Patterns of medication use for lupus in a large cohort of patients confirm the unmet clinical need for new therapies. Data from the Asia-Pacific Lupus Collaboration was used to assess treatment persistence in 2,860 patients across 19,804 visits between 2013 and 2018. The study, published in Arthritis Care and Research, found triple therapy – prednisolone, ...

Already a member?

Login to keep reading.

© 2021 the limbic